Walid L. Shaib
Northwest Behavioral Medicine(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Colorectal Cancer Treatments and Studies, Neuroendocrine Tumor Research Advances, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms(2019)399 cited
- → Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma(2018)376 cited
- → Appendiceal Mucinous Neoplasms: Diagnosis and Management(2017)241 cited
- → The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy(2018)158 cited
- → Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy(2019)122 cited
- → A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours(2017)93 cited
- → Inhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer(2016)78 cited
- → Incidence and Survival of Appendiceal Mucinous Neoplasms(2015)77 cited
- → A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer.(2017)76 cited
- → Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases(2016)72 cited